Aileron Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
40.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.65
|
-1.40
|
0.25
|
15.15%
|
|
2022-06-30
|
-1.80
|
-1.80
|
0.00
|
0.00%
|
|
2022-03-31
|
-1.53
|
-1.80
|
-0.27
|
-17.65%
|
|
2021-12-31
|
-1.60
|
-1.60
|
0.00
|
0.00%
|
|
2021-09-30
|
-1.40
|
-1.40
|
0.00
|
0.00%
|
|
2021-06-30
|
-1.47
|
-1.20
|
0.27
|
18.37%
|
|
2021-03-31
|
-1.07
|
-1.60
|
-0.53
|
-49.53%
|
|
2020-12-31
|
-2.55
|
-2.40
|
0.15
|
5.88%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-5.00
|
|
2021-12-31
|
-5.80
|
|
2020-12-31
|
-2.91
|
|
2019-12-31
|
-1.29
|
|
2018-12-31
|
-8.49
|